Top Executive Joins Caliber Imaging & Diagnostics, Inc.
ROCHESTER, N.Y., Jan. 7, 2013 /PRNewswire/ -- Caliber Imaging & Diagnostics, Inc., (Caliber I.D.) formerly Lucid, Inc. (OTBB: LCDX) announced today that Utica, NY native, Rick Stathes, has joined Caliber Imaging & Diagnostics, Inc. as Vice President of Sales and Marketing.
"I'm excited for the opportunity to be part of this innovative team," said Mr. Stathes. "I have no doubt that our products will have a huge impact on improving the standards of care in many areas of medical diagnosis and treatment. Our products give clinicians and researchers a non-invasive window into the skin."
Mr. Stathes has over 25 years of executive experience with technology driven companies, including American Aerogel Corporation, Conseco Insurance, Centennial Technologies, PSC Inc. and Hewlett Packard Company, is a Veteran of the United States Air Force and has his BS degree in Business from Utica College of Syracuse University.
As Vice President of Sales and Marketing, Mr. Stathes will focus on opening new channels of distribution, building customer support infrastructure, expanding the sales force, targeting new applications for the technology, and creating more awareness of the technology in domestic and international markets. Additionally, he is looking forward to developing relationships with academic centers to increase adoption of the technology in research and clinical applications through accredited training programs.
"Caliber I.D. is poised for high growth with the introduction of its new hand-held portable medical imaging devices, and Rick with his extensive experience in sales and marketing, is a perfect fit for our company at this time," said L. Michael Hone, President and CEO at Caliber I.D.
Mr. Hone went on to say that, "We believe that Caliber I.D. has raised the bar in non-invasive, cellular imaging with an FDA-cleared imaging technology platform-the VivaScope®- that introduces clinicians and researchers to a powerful new world in which living cells and cellular processes can be viewed in real-time without a biopsy."
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' platform of products offer increased productivity from the doctor's office to the surgeon's operating room. Today, the future of skin cancer diagnosis is here: an integrated platform of tools and technology for accurate diagnoses quickly and routinely. Caliber I.D. products provide precise accuracy, consistent reliability, and online backup that all combine to lead to life-saving early diagnosis. Wherever you are in the continuum of skin imaging and diagnosis, this is not just best in class. This is a new class. For more information about Caliber I.D. and its products, please visit www.caliberid.com.
VivaScope® is a registered trademark of Caliber Imaging & Diagnostics.
This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes," "assumes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the SEC.
CONTACT: Richard Pulsifer, Chief Financial Officer, 617-348-9821
SOURCE Caliber Imaging & Diagnostics, Inc.